Question 1

Has Till Hansen received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $488,148 in general payments to Till Hansen across 810 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Till Hansen did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Till Hansen come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Novo Nordisk	334	$214,237
Lilly USA, LLC	362	$206,865
AstraZeneca	73	$47,670
Corcept Therapeutics	18	$15,317
Johnson & Johnson	10	$3,162
Amarin Pharma, Inc.	4	$259
Nxstage Medical, Inc.	3	$175
Radius Health, Inc.	2	$145
Boehringer Ingelheim	2	$141
Bayer	1	$100
Sanofi-aventis U.S. LLC	1	$78

Till Hansen

Payments from drug & device makers

Who reported the general payments

How this compares

Other endocrinology, diabetes & metabolism in Wailuku